findmyKOL

Nadege Gunn, MD

Basic profile

Gastroenterology

ORCIDNPI
RegionWaco, TX · South CentralSpecialtyGastroenterologyFocusGastroenterology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Nadege Gunn is a Gastroenterology physician. OpenAlex indexes 45 publications with 2,535 citations (h-index 14).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
45publications

Distinct works indexed by OpenAlex, matched via ORCID.

2,535citations

Total citations across indexed works.

14h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
34companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

6600 Fish Pond Rd Ste 103
Waco, TX 767102582

Telephone

254-294-4780

Provider last certified this registry record 1 Aug 2023.

View the NPPES registry record

Industry payments

34 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    42.6%
    Bile Acid42.6%
    Ursodiol100%
    Part D<11 patients
  • Anti-infectives

    41.2%
    Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor23.5%
    Epclusa100%
    Part D<11 patients
    Nucleoside and nucleotide reverse transcriptase inhibitors17.6%
    Vemlidy100%
    Part D<11 patients
  • Cardiovascular

    16.2%
    Aldosterone antagonist (MRA)16.2%
    Spironolactone100%
    Part D<11 patients
Where care is delivered (Part B), 20200% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”